Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

BC biologists identify alternative brain cancer treatment

22.02.2007
High-fat, low-carbohydrate diet significantly slows tumor growth and enhances health in mice

Boston College biologists have identified an alternative, diet-based method of treating brain cancer that does not involve administering toxic chemicals, radiation or invasive surgery.

The biologists found that KetoCal, a commercially available high-fat, low-carbohydrate diet designed to treat epilepsy in children, can significantly decrease the growth of brain tumors in laboratory mice. Moreover, the diet significantly enhanced health and survival rates relative to mice in control groups who consumed a standard low-fat, high-carbohydrate diet.

The findings were based on a study published this week in the online journal Nutrition & Metabolism.

“KetoCal represents a novel alternative therapy for malignant brain cancer,” said Boston College Biology Professor Tom Seyfried, who conceived and supervised the study. “While the tumors did not vanish in the mice who received the strict KetoCal diet, they got significantly smaller and the animals lived significantly longer. And compared to radiation, chemotherapy and surgery, KetoCal is a relatively inexpensive treatment option.”

Malignant brain cancer is one of the most lethal types of cancer in adults and is the second leading cause of cancer death in children. Many current ways of treating the disease fail to provide long-term management because they ineffectively target tumor cells and harm the health and vitality of normal brain cells.

The KetoCal diet gets around this dilemma by essentially starving the brain tumor cells of the sugary molecules on which they rely for growth and survival. Because of its special composition, the diet deprives the tumor cells of the glucose they need; at the same time, the diet provides normal brain cells with ketones, a class of organic compounds they can metabolize effectively but the tumor cells cannot.

In their experiment, the BC team surgically implanted two different kinds of tumors into the brains of male mice. The mice were then divided into three groups. One group was fed a high-carbohydrate mouse chow, one was given unlimited amounts of KetoCal, and the final group was given KetoCal in a restricted dosage.

The researchers found that in the mice on the restricted diet, KetoCal decreased the growth of brain tumors by between 35 percent and 65 percent. Moreover, survival rates were higher in the mice on the restricted diet.

“This preclinical study indicates that KetoCal is a safe and effective diet therapy and should be considered as an alternative therapeutic option for malignant brain cancer,” the researchers wrote.

KetoCal is manufactured by Nutricia North America. The study authors report they have no financial interests in the company, although it did provide the KetoCal used in the experiments as a gift.

The journal article’s lead author is Weihua Zhou, a research technician in the Boston College Biology Department. Co-authors include Seyfried, Purna Mukherjee, Michael Kiebish, William Markis and John Mantis.

Greg Frost | EurekAlert!
Further information:
http://www.bc.edu

Further reports about: Biologists KetoCal brain tumor significantly tumor cells

More articles from Life Sciences:

nachricht When Air is in Short Supply - Shedding light on plant stress reactions when oxygen runs short
23.03.2017 | Institut für Pflanzenbiochemie

nachricht WPI team grows heart tissue on spinach leaves
23.03.2017 | Worcester Polytechnic Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

When Air is in Short Supply - Shedding light on plant stress reactions when oxygen runs short

23.03.2017 | Life Sciences

Researchers use light to remotely control curvature of plastics

23.03.2017 | Power and Electrical Engineering

Sea ice extent sinks to record lows at both poles

23.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>